Arcutis’s Phase III AD Win Bodes Well For Soon-To-Report Second Study

 
• By Alaric DeArment
  
Arcutis announced Phase III results for roflumilast in atopic dermatitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D